Three avirulent insertional mutants of Erysipelothrix rhusiopathiae were obtained by the technique of transposon mutagenesis with the self-conjugative transposon Tn916. The interactions between murine polymorphonuclear leukocytes and parent and mutant strains were studied in vitro. In the presence of normal serum, the virulent parent strain was resistant to phagocytosis, whereas the avirulent mutant strains were efficiently phagocytosed. In the presence of immune serum, the parent and the mutant strains were both efficiently phagocytosed. Electron microscopic examination of the parent strain demonstrated the presence of a structure resembling a capsule which was absent on the mutant strains, suggesting that a capsule may be involved in virulence. This was confirmed in studies in which an avirulent mutant strain reverted to virulence following acquisition of a capsule when the transposon was lost by spontaneous excision. These results strongly suggest that virulence of E. rhusiopathiae is associated, at least in part, with resistance to phagocytosis by polymorphonuclear leukocytes and that this antiphagocytic ability of the bacterium results from its possession of a capsule.
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Erysipelothrix rhusiopathiae is a slender, gram-positive, rodshaped bacterium that causes a variety of diseases in animals and birds as well as in humans. In swine, E. rhusiopathiae may cause acute septicemic disease or chronic endocarditis and polyarthritis (26) . The mechanisms of pathogenicity of E. rhusiopathiae and of innate or acquired immunity to erysipelas infection are not clearly understood (25) . It has been reported that E. rhusiopathiae may have a capsule which may be important in the pathogenicity of the disease (8) . It is also known that strains of E. rhusiopathiae vary in virulence (26) . These indications have enabled us to propose a hypothesis that E. rhusiopathiae has a capsule which plays an important role in virulence and that the variation in virulence is due to the varying degrees of capsule expression on the bacterial surface. To test this hypothesis, we used transposon mutagenesis to generate isogenic mutants with specific defects in capsule production or structure. Transposon mutagenesis is a useful tool to derive isogenic mutants that differ in expression of a specific virulence factor and has been used successfully in the study of pathogenesis of several pathogenic species of bacteria (3, 9, 12, 17, 22) . In this report, we describe the isolation of avirulent mutants by transposon mutagenesis with Tn916. By comparing the isogenic strains, we found that there was a correlation between virulence of E. rhusiopathiae and the ability of the bacterium to resist phagocytosis by polymorphonuclear leukocytes (PMNs) phate-buffered saline (PBS), and postfixed in 1% osmium tetroxide. They were dehydrated in alcohol and embedded in epoxy resin. Thin sections were stained with uranyl acetate and lead citrate and examined with a JEOL 1200EX transmission electron microscope.
Preparation of DNA probe. A probe was prepared from plasmid pAM120 (5) and labeled with digoxigenin-dUTP (DIG DNA Labeling and Detection Kit, Nonradioactive; Boehringer Mannheim-Yamanouchi, Tokyo, Japan).
DNA preparation and Southern hybridization. E. rhusiopathiae DNA was prepared by the method of Galan and Timoney (4) . The whole-cell DNAs isolated from parent and mutant strains were digested with the restriction enzyme EcoRI or HindlIl as suggested by the manufacturer. The DNA fragments were transferred onto nylon membranes (Nytran; Schleicher & Schuell, Dassel, Germany) by the vacuum transfer method with VacuGene (Pharmacia, Uppsala, Sweden) without depurination, as suggested by the manufacturer. Prehybridization and hybridization were carried out at 68°C for 4 h and for 16 to 20 h, respectively, with the hybridization buffer in the commercial kit. After hybridization, nylon membranes were washed twice at room temperature for 5 min in 2x saline sodium citrate (SSC; lx SSC is 0.15 M sodium chloride plus 0.015 M sodium citrate, pH 7.2) containing 0.1% sodium dodecyl sulfate (SDS) and then given two 15-min washes at 68°C in 0.1X SSC containing 0.1% SDS. Immunological detection of hybridized digoxigenin-labeled probe was performed with the commercial kit (Boehringer Mannheim-Yamanouchi).
Virulence testing. Bacterial strains to be tested were grown overnight at 37°C in BHI-T80 broth and then diluted with BHI-T80 broth. Groups of five animals were inoculated intraperitoneally with 0.1 ml of the dilutions and observed for death over a period of 14 days. The 50% lethal doses (LD50s) were calculated by the Reed and Muench method (14) .
Preparation of sera. Normal mouse sera were obtained from normal mice and pooled. Antisera to E. rhusiopathiae were obtained from mice 20 days after subcutaneous immunization with 108 cells of an attenuated vaccine strain, Koganei 65-0.15, of E. rhusiopathiae (18) . Pooled antiserum from these immunized mice had an immunoglobulin G titer of 1:4,096 as determined by an enzyme-linked immunosorbent assay that used intact, formalin-killed E. rhusiopathiae as the antigen. The protective activity of antiserum to E. rhusiopathiae for mice was found only in the immunoglobulin G fraction (27) . Pooled sera were stored at -70°C until use.
Phagocytosis assay. The isolation of PMNs and the phagocytosis assay were determined as previously described (1), with minor modifications. Briefly, mice were killed with chloroform 4 h after intraperitoneal injection of 1.0 ml of sterile 10% Proteose Peptone (Difco), and the peritoneal exudate cells were obtained by peritoneal lavage with 5.0 ml of Hanks' balanced saline solution (Sigma Chemical Co., St. Louis, Mo.) containing 0.01 M EDTA. PMNs were separated with FicollPaque (Pharmacia), washed twice, and resuspended in RPMI-1640 medium (Sigma) containing 0.25% bovine serum albumin (RPMI-BSA). Bacteria (107/ml) were incubated with 106
PMNs per ml in a total volume of 1.0 ml of RPMI-BSA containing 10% pooled mouse serum under rotation (8 rpm) for 60 min at 37°C. Phagocytosis was stopped by shaking the tubes at 4°C, and the uningested bacteria were removed by two washes with cold PBS containing 5% fetal bovine serum (FBS-PBS) and resuspended in 2.0 ml of FBS-PBS. Cytospin smears were prepared and stained with Giemsa's solution and examined by light microscopy with an oil immersion objective. The results were expressed as the phagocytic index (1 (Fig. 1D) . The excision of Tn916 was confirmed by the susceptibility to tetracycline and Southern hybridization.
Electron microscopic studies of cell surfaces of parent and mutant strains. Colonies on agar plates were stained with uranyl acetate and lead citrate and then observed under electron microscopy. Capsule materials were observed as an electron-dense layer outside the outer membranes on the parent and 33H6-R strains ( Fig. 2A and C) , but not on the mutant strain 33H6 (Fig. 2B ; data not shown for 28G5 and 28G12). These capsule materials were especially thick at both polar ends of the bacterial cell.
Southern hybridization. The insertions of Tn916 in several capsule-negative clones and in the capsule-producing revertant clone were confirmed by Southern hybridization with digoxigenin-labeled Tn916 to probe EcoRI digests of whole-cell DNA. EcoRI does not cut within the Tn916 sequence (5) . The parent and 33H6-R strains did not contain DNA sequences that hybridized with the probe, and hybridizations of the DNA fragments from these mutants demonstrated Tn916 insertions (Fig. 3A) . The sizes of the DNA fragments, consisting of the entire transposon and flanking sequence of the bacterium, were not identical among the mutants, suggesting that Tn916 was inserted at different sites. To determine the number of copies of Tn916 in mutant strains, whole-cell DNA was digested with HindIll (Fig. 3B) whereas 28G5 showed more than six bands, suggesting that multiple copies were inserted into the chromosome of 28G5.
Virulence of mutants in mice. To compare the virulence of strains, mice were inoculated intraperitoneally with bacterial strains and the LD50s were determined 14 days postinoculation. The intraperitoneal LD50s of the parent and 33H6-R strains were 10 5 and 103-9 CFU per mouse, respectively. In contrast, capsule-negative mutants were totally avirulent for mice at a dose of 108 bacteria. These results indicate that the loss of capsule expression was associated with loss of virulence and that virulence was restored when the mutant lost transposon Tn916 and regained a capsule. The insertion of transposon Tn916 into the E. rhusiopathiae chromosome seemed not, in itself, to affect its virulence, since the other six transconjugants containing both Tn916 and a capsule were still virulent (data not shown).
Phagocytosis of E. rhusiopathiae by murine PMNs in vitro. The phagocytosis of E. rhusiopathiae by PMNs was studied after 60 min of incubation (Fig. 4) . In the presence of normal serum, the parent and 33H6-R strains resisted phagocytosis. In contrast, all of the mutant strains, 33H6, 28G5, and 28G12, were efficiently phagocytosed, although 28G5 was more phagocytosed than the other mutant strains. In the presence of immune serum, the parent and 33H6-R strains were efficiently phagocytosed, suggesting that antisera act as opsonins (25) . Avirulent mutants were phagocytosed more efficiently than either the parent or the 33H6-R strain.
DISCUSSION
The results of this study have demonstrated that virulence of E. rhusiopathiae is associated, at least in part, with resistance to phagocytosis by PMNs and that this ability is closely related to the existence of a capsule on its cell surface.
Capsules are important virulence factors of the pathogenic bacteria, such as Klebsiella pneumoniae (2, 19) and Streptococcus pneumoniae (10) . The primary function of bacterial capsules in pathogenesis is to confer on the pathogen the ability to evade phagocytic host defense mechanisms (6) , and it is well known that specific antiserum is effective in protection against   FIG. 4 encapsulated pathogens (16) . A previous report (8) has suggested that E. rhusiopathiae may have a capsule and it may be important in the pathogenesis of the disease. In E. rhusiopathiae infection, the efficacy of antiserum to E. rhusiopathiae for treatment (26) and the importance of serum opsonins are well known (21, 25) . From these observations, we hypothesized the following: (i) this organism has antiphagocytic cell surface component(s) such as a capsule, and (ii) the level of protection induced by specific antiserum is similar to that observed in other encapsulated bacterial infections. To test this hypothesis, transposon mutagenesis was performed to create mutants altered in capsule expression. Tn916 was successfully introduced into the chromosome of E. rhusiopathiae by filter mating. Following mutagenesis, we selected transconjugants that changed their colonial morphology on agar plates. Electron microscopy showed the presence of an external layer, suggesting a capsule on the parent strain and its absence on all virulence-reduced mutants. This suggested that the change of capsule production or structure might affect colonial morphology. The correlation of the presence of capsule antigens on the cell surface with colonial morphology has also been shown in several pathogens, such as Kiebsiella pneumoniae (13, 19) , Pasteurella multocida (15) , and Staphylococcus aureus (11) , adding further support to our contention that E. rhusiopathiae does contain a capsule.
The results of in vitro phagocytosis assays revealed that in the presence of normal serum, the parent and 33H6-R strains resisted phagocytosis by PMNs, whereas capsule-negative mutant strains were efficiently phagocytosed. However, the number of phagocytosed bacteria in the presence of normal serum was greater in the case of 28G5 than in the cases of 33H6 and 28G12. This result suggests that the mutants 33H6 and 28G12 still have the ability to resist phagocytosis more than 28G5 and that this ability is the effect of the small amount of capsule material produced on the cell surface, although these avirulent mutants did not have an intact capsule detected by transmission electron microscopy. Virulence studies with mice indicated that the LD50s of the mutant strains were >10,000-fold higher than that of the parent strain. These results strongly suggest that virulence of E. rhusiopathiae is associated, at least in part, with resistance to phagocytosis by PMNs and that this property is a function of a capsule located on the bacterial surface.
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Little is known about the virulence factors of E. rhusiopathiae except that there is a correlation between the amount of the enzyme neuraminidase produced and the virulence of E. rhusiopathiae strains (7) and that virulent strains of the organism adhered better to porcine kidney cells in vitro than did avirulent strains (20) . However, avirulent mutants produced neuraminidase as well as the parent strain and there was no difference in adherence to porcine kidney cells in vitro between parent and mutant strains (data not shown).
Southern hybridization analysis of EcoRI-digested and HindIII-digested DNA indicated a single transposon insertion in the two mutants (33H6 and 28G12) and more than one insertion in 28G5. However, the points of transposition were different in each, suggesting that Tn916 was insertionally inactivated at different loci. Since it is likely that several genes are involved in biosynthesis, assembly, transport, and regulation of capsule production (9, 17) , these results are not surprising.
The presence of a capsule in E. rhusiopathiae and its potential role in pathogenesis have been discussed (8) ; however, evidence that the bacterium has a capsule is lacking. One reason for this may be its lability and its easy removal from the bacterial cell surface by preparation of samples. This is supported by White and Verwey (23, 24) , who reported that the protective antigen, a 200-kDa glycolipoprotein complex, of E. rhusiopathiae was released into the culture medium. Assuming that the capsule of E. rhusiopathiae is involved in protection and is easily removed from the bacterial cell surface, it will be interesting to compare the protective abilities of culture filtrates made with the virulent strain and the avirulent mutants constructed in this study. We are presently investigating whether the protective antigen reported by White and Verwey (23, 24) is identical to the capsule described here.
